Cargando…
Immunization against Leishmania major Infection Using LACK- and IL-12-Expressing Lactococcus lactis Induces Delay in Footpad Swelling
BACKGROUND: Leishmania is a mammalian parasite affecting over 12 million individuals worldwide. Current treatments are expensive, cause severe side effects, and emerging drug resistance has been reported. Vaccination is the most cost-effective means to control infectious disease but currently there...
Autores principales: | Hugentobler, Felix, Yam, Karen K., Gillard, Joshua, Mahbuba, Raya, Olivier, Martin, Cousineau, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277590/ https://www.ncbi.nlm.nih.gov/pubmed/22348031 http://dx.doi.org/10.1371/journal.pone.0030945 |
Ejemplares similares
-
Trans-splicing of the Ll.LtrB group II intron in Lactococcus lactis
por: Belhocine, Kamila, et al.
Publicado: (2007) -
The circle to lariat ratio of the Ll.LtrB group II intron from Lactococcus lactis is greatly influenced by a variety of biological determinants in vivo
por: Monat, Caroline, et al.
Publicado: (2020) -
The Ll.LtrB intron from Lactococcus lactis excises as circles in vivo: insights into the group II intron circularization pathway
por: Monat, Caroline, et al.
Publicado: (2015) -
Intranasal Application of Lactococcus lactis W136 Is Safe in Chronic Rhinosinusitis Patients With Previous Sinus Surgery
por: Endam, Leandra Mfuna, et al.
Publicado: (2020) -
The Lactococcus lactis Pan-Plasmidome
por: Kelleher, Philip, et al.
Publicado: (2019)